Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

欧化达 - NMPA Drug Approval Details

Approvals/NMPA/Ranitidine Hydrochloride Tablets

Approved

化学药品

Ranitidine Hydrochloride Tablets

广州欧化药业有限公司🇨🇳 National Medical Products Administration

Approval Date: Mar 11, 2020
Approval ID: 7Leaf1oGwfV
Company: 广州欧化药业有限公司
Type: 化学药品

Approval Details

Approval Id: 7Leaf1oGwfV
Approval Number: 国药准字H44022608
Generic Name: 盐酸雷尼替丁片
Generic Name En: Ranitidine Hydrochloride Tablets
Trade Name: 欧化达
Brand Name: 欧化达
Drug Type: 化学药品
Dosage Form: 片剂(薄膜衣)
Strength: 按C13H22N4O3S计算 150mg
Reg Date: 2020-03-11
Company Name: 广州欧化药业有限公司
Company Address: 广州市增城区宁西街创新大道14号3栋1701室
Production Company Name: 广州欧化药业有限公司(药品上市许可持有人)
Production Company Address: 广州增城市中新镇中新工业园工业大道1号（注册地址）
Company Detail Path: /organization/yan-zhou-ou-hua-yao-ye-you-xian-gong-si

Approved

Quick Info

Agency

NMPA

Country

🇨🇳

Approval Date

Mar 11, 2020

Approval ID

7Leaf1oGwfV

Type

化学药品

Back to NMPA Approvals